格隆汇4月17日丨开拓药业-B(09939.HK)公告,公司董事会获童友之博士(为公司董事会主席、执行董事兼行政总裁)通知,其于2025年3月28日通过其全资拥有公司KT International Investment Limited于公开市场以自有资金259,000港元(平均成交价格为每股1.295港元)增持公司200,000股股份,占公司于本公告日期已发行股本总额约0.0447%。此外,童...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.